Mangalam Drugs & Organics Limited is a renowned manufacturer and distributor of drugs, medicines, and related products in both the domestic and international markets. The company specializes in producing a diverse range of active pharmaceutical ingredients, intermediates, specialty chemicals, and impurities. These products are utilized in various applications such as anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral treatments. Established in 1972, the company is headquartered in Mumbai, India.
Navigation section
Mangalam Drugs And Organics Limited
- 116.00 -3.71(-3.10%) 116.00 -3.15(-2.64%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 113.80 115.70 | 119.99 118.05 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 90.80 (28-Mar-2024) 85.16 (15-Apr-2024) | 144.99 (26-Aug-2024) 144.65 (26-Aug-2024) |
- Open
- 119.99 118.05
- Previous Close
- 119.71 119.15
- Volume
- 0.46
- Total Traded value
- 0.53 (₹ Lakhs)
- Upper circuit
- 143.65 128.54
- Lower circuit
- 95.76 85.70
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 0 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹1.84 Cr |
| PE Ratio (TTM): | 20.03 |
| PB Ratio: | 1.32 |
| Industry P/E: | 20.15 |
| Debt to Equity: | - |
| ROE: | 6.62 |
| EPS (TTM): | 5.95 |
| Book Value: | 61.45 |
| Face Value: | 10.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 81.56 Cr | 87.47 Cr | 91.11 Cr | 63.33 Cr | 108.33 Cr |
| Profit | -3.56 Cr | -9.54 Cr | -4.39 Cr | 0.43 Cr | 2.23 Cr |
| Expense | 86.34 Cr | 97.77 Cr | 97.05 Cr | 62.96 Cr | 105.20 Cr |
| Comprehensive income | -3.53 Cr | -9.50 Cr | -4.17 Cr | 0.28 Cr | 2.26 Cr |
| EPS | -2.25 | -6.02 | -2.77 | 0.27 | 1.41 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Mangalam Drugs And Organics Limited | May, 2005 May, 2005 | Pharmaceuticals Pharmaceuticals | MANGALAM MANGALAM |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Mangalam Drugs And Organics Limited FAQ's
What is the range of today's stock performance for Mangalam Drugs And Organics Limited?
Today's stock performance witnessed a fluctuation from a minimum of 113.80 on the NSE (National Stock Exchange) to a maximum of 119.99. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 115.70 to a high of 118.05.
What are the 52-week low and high values for Mangalam Drugs And Organics Limited?
The stock's performance over the past 52 weeks reveals a low of 90.80 (occurred on 28-Mar-2024) and a high of 144.99 (achieved on 26-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 85.16 (on 15-Apr-2024), and the 52-week high is 144.65 (on 26-Aug-2024).
What was the opening and previous closing prices for Mangalam Drugs And Organics Limited?
The stock's performance over the past 52 weeks reveals a low of 90.80 (occurred on 28-Mar-2024) and a high of 144.99 (achieved on 26-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 85.16 (on 15-Apr-2024), and the 52-week high is 144.65 (on 26-Aug-2024).
What is the total volume and traded value for Mangalam Drugs And Organics Limited for the day?
The total volume is 0, and the total traded value is 0.53 (₹ Lakhs).
What are the upper and lower circuit limits for Mangalam Drugs And Organics Limited?
The upper circuit limit is 143.65, and the lower circuit limit is 95.76.
What is the market cap and PE ratio for Mangalam Drugs And Organics Limited?
The market cap is ₹1.84 Cr, and the PE ratio (TTM) is 20.15.
What is the PB ratio, industry P/E, and debt to equity ratio for Mangalam Drugs And Organics Limited?
The PB ratio is 1.89, industry P/E is 20.15 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Mangalam Drugs And Organics Limited?
ROE is 6.62, EPS is 5.95, book value is 61.45
What are the revenue and profit figures for the latest quarter and previous quarters for Mangalam Drugs And Organics Limited?
In Sep 2023, Revenue is ₹815555000.00, and Profit is ₹-35597000.00. In Jun 2023, Revenue is ₹874680000.00, and Profit is ₹-95354000.00.
When was Mangalam Drugs And Organics Limited listed, and what industry does it belong to?
The company, Mangalam Drugs And Organics Limited, was listed in May 2005 and belongs to the Pharmaceuticals industry. Its NSE symbol is MANGALAM.
What is the current shareholding pattern of the Mangalam Drugs And Organics Limited?
As of latest available update, promoters hold 50.32%, the public holds 49.68%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
